أوروبا · وكالات وأخبار لحظية · Reuters US Markets

India's Cipla misses second-quarter profit view on muted US sales

نشره Reuters US Markets · المملكة المتحدة منذ 12 س

Cipla , India's third-largest drugmaker by revenue, missed second-quarter ‌profit estimates on Tuesday, as muted sales of generic Revlimid and stiff ⁠competition weighed on…

اقرأ المقال كاملًا على Reuters US Markets سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.reuters.com)

يستحق القراءة أيضًا

TASS

Attempts to exclude Russian from gas market have serious consequences

Anadolu Agency

ByteDance founder Zhang Yiming regains top spot on China’s rich list amid AI boom

Reuters Asia Markets

Who's exposed to Indonesia's market meltdown?

Reuters Europe Markets

Norway's prime minister, Finland's president in phone call with Putin

Reuters Technology

Initial global sales of Apple iPhone 18 Pro higher than 17 series - Counterpoint Research

Reuters Breakingviews